Standardization Of Protein Immunoprocedures Choriogonadotropin (Cg)

References

• Wide L, Gemzell C A. An immunological pregnancy test. Acta Endocrinol 1960; 35: 261–267
   PubMedGoogle Scholar
• Chard T. Pregnancy tests: a review. Hum Re-prod 1992; 7: 701–710
   PubMed Web of Science ®Google Scholar
• Vaitukaitis J L, Braunstein G D, Ross G T. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol 1972; 113: 751–758
   PubMed Web of Science ®Google Scholar
• Chen H-C, Hodgen G D, Matsuura S, Lin L J, Gross E, Reichert L EJ, et al. Evidence for a go nadotropin from nonpregnant subjects that has physiological, immunological, and biological similarities to human chorionic gonadotropin. Proc Natl Acad Sci 1976; 73: 2885–2889
   PubMed Web of Science ®Google Scholar
• Hussa R O. The clinical marker hCG. Praeger, New York 1987
   Google Scholar
• Pierce J G, Parsons T F. Glycoprotein hormones: Structure and function. Ann Rev Biochem 1981; 50: 465–495
   PubMed Web of Science ®Google Scholar
• Hussa R. Biosynthesis of human chorionic go nadotropin. Endocrinol Rev 1980; 1: 268–294
   PubMedGoogle Scholar
• Gordon W L, Ward D N. Structural aspects of luteinizing hormone actions. Luteinizing hormone action and receptors, M A Ascoli. CRC Press, Boca Raton 1985; 173–197
   Google Scholar
• Mise T, Bahl O P. Assignment of disulfide bonds in the alpha subunit of human chorionic gona dotropin. J Biol Chem 1980; 255: 8516–22
   PubMed Web of Science ®Google Scholar
• Mise T, Bahl O P. Assignment of disulfide bonds in the beta subunit of human chorionic gonado tropin. J Biol Chem 1981; 256: 6587–92
   PubMed Web of Science ®Google Scholar
• Birken S, Krichevsky A, O'Connor J, Lustbader J W, Canfield R. Chemistry and imrnunochem-istry of hCG, its subunits, and its fragments. Glycoprotein hormones, Serono Symposia, W W Chin, I Boime. Raven Press, Norwell 1990; 45–61
   Google Scholar
• Cole L A, Kardana A, Birken S. The isomers, subunits and fragments of hCG. Structure-function relationship of gonadotropins, D Belief, J-M Bidart. Raven Press, New York 1989; 59–80
   Google Scholar
• Nilson J H, Bokar J A, Clay C M, Farmerie T A, Fenstermaker R A, Hamernik D L, Keri R A. Different combinations of regulatory elements may explain why placenta-specific expression of the glycoprotein hormone a-subunit gene occurs only in primates and horses. Biol Reprod 1991; 44: 231–237
   PubMed Web of Science ®Google Scholar
• Cole L A, Kroll T G, Ruddon R W, Hussa R O. Differential occurrence of free beta and free alpha subunits of human chorionic gonadotropin (hCG) in pregnancy sera. J Clin Endocri nol Metab 1984; 58: 1200–1202
   PubMed Web of Science ®Google Scholar
• Ozturk M, Bellet D, Manil L, Hennen G, Frydman R, Wands J. Physiological studies of human chorionic gonadotropin (hCG), cthCG and BhCG as measured by specific monoclonal immunoradiometric assays. Endocrinol 1987; 120: 549–558
   PubMed Web of Science ®Google Scholar
• Alfthan H, Schroder J, Fraser R, Koskimies A, Halila H, Stenman U-H. Choriogonadotropin and its fj subunit separated by hydrophobic-in-teraction chromatography and quantified in serum during pregnancy by time-resolved im-munofluorometric assays. Clin Chem 1988; 34: 1758–1762
   PubMed Web of Science ®Google Scholar
• Schroeder H R, Halter C M. Specificity of human fi-choriogonadotropin assays for the hormone and for an immunoreactive fragment present in the urine during normal pregnancy. Clin Chem 1983; 29: 667–671
   PubMed Web of Science ®Google Scholar
• Kato Y, Braunstein G D. β-core fragment is a major form of immunoreactive urinary cho rionic gonadotropin in human pregnancy. J Clin Endocrinol Metab 1988; 66: 1197–201
   PubMed Web of Science ®Google Scholar
• Blithe D L, Wehmann R E, Nisulaβ-core B C. Chemical and clinical properties. Trends Endo crinol Metab 1990; 1: 394–398
   PubMed Web of Science ®Google Scholar
• Ami S, Rosa C, Birken S, Canfield R, Nisula B. Carboxyterminal peptide fragments of the beta subunit are urinary products of the metabolism of desialylated human choriogonadotropin. J Clin Invest 1985; 76: 350–6
   PubMed Web of Science ®Google Scholar
• Alfthan H, Schroder J, Stenman U-H. Demon stration of the core fihCG fragment in serum of pregnant women and cancer patients. Interna tional Society for Oncodevelopmental Biology and Medicine, Freiburg 1989; 18–229
   Google Scholar
• Alfthan H, Haglund C, Dabek J, Stenman U-H. Concentrations of hCG, BhCG and cBhCG in serum and urine of nonpregnant women and men. Clin Chem 1992; 38: 1981–7
   PubMed Web of Science ®Google Scholar
• Bagshawe K D. Choriocarcinoma. A model for tumor markers. Acta Oncol 1992; 31: 99–106
   PubMed Web of Science ®Google Scholar
• Braunstein G D, Karow W G, Gentry W C, Rasor J, Wade M E. First-trimester chorionic gonado tropin measurements as an aid in the diagnosis of early pregnancy disorders. Am J Obstet Gynecol 1978; 131: 25–32
   PubMed Web of Science ®Google Scholar
• Cacciatore B, Ylostalo P, Stenman U-H. Suspected ectopic pregnancy: ultrasound find ings and hCG levels assessed by an immunoflu-orometric assay. Brit J Obstet Gynecol 1988; 95: 497–502
   PubMedGoogle Scholar
• Norman R J, Buck R, Reddi K. Urinary hCG test in ectopic pregnancy [letter]. Fertil Steril 1986; 45
   Web of Science ®Google Scholar
• Cacciatore B, Stenman U-H P. Y. Comparison of abdominal and vaginal sonography in sus pected ectopic pregnancy. Obst Gynecol 1989; 73: 770–774
   PubMed Web of Science ®Google Scholar
• Platt L D, Carlson D E. Prenatal diagnosis -When and how?. N Engl J Med 1992; 327: 636–638
   PubMed Web of Science ®Google Scholar
• Spencer K, Macri J N, Aitken D A, Connor J M. Free beta-hCG as first-trimester marker for fetal trisomy [letter]. Lancet 1992; 339
   Web of Science ®Google Scholar
• Ozturk M, Milunsky A, Brambati B, Sachs E S, Miller S L, Wands J R. Abnormal maternal serum levels of human chorionic gonadotropin free subunits in trisomy 18. Am J Med Genet 1990; 36: 480–3
   PubMed Web of Science ®Google Scholar
• Jones W B. Gestational trophoblastic disease: what have we learned in the past decade?. Am J Obstet Gynecol 1990; 162: 1286–95
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Klieber R, Mann K, Marth C, Tabarelli M, Wick G, Berger P. Free alpha-sub-unit, free beta-subunit of human chorionic go nadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer pa tients. Clin Chem 1992; 38: 370–6
   PubMed Web of Science ®Google Scholar
• Braunstein G D, Vaitukaitis J L, Carbone P P, Ross G T. Ectopic production of human cho rionic gonadotrophin by neoplasms. Ann Int Med 1973; 78: 39–45
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H, Ranta T, Vartiainen E, Jalkanen J, Seppala M. Serum levels of human chorionic gonadotropin in nonpregnant women and men are modulated by gonado tropin releasing hormone and sex steroids. J Clin Endocrinol Metab 1987; 64: 730–736
   PubMed Web of Science ®Google Scholar
• Iles R K, Jenkins B J, Oliver R T, Blandy J P, Chard T. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic uro thelial cancer. Br J Urol 1989; 64: 241–4
   PubMedGoogle Scholar
• Alfthan H, Haglund C, Roberts P, Stenman U-H. Elevation of free B subunit of human chorio gonadotropin and core 8 fragment of human choriogonadotropin in serum and urine of pa tients with malignant pancreatic and biliary disease. Cancer Res 1992; 52: 4628–4633
   PubMed Web of Science ®Google Scholar
• Hoermann R, Gerbes A L, Spoettl G, Jüngst D, Mann K. Immunoreactive human chorionic go nadotropin and its free B subunit in serum and ascites of patients with malignant tumors. Cancer Res 1992; 52: 1520–1524
   PubMed Web of Science ®Google Scholar
• Marcillac I, Troalen F, Bidart J-M, Ghillani P, Ribrag V, Escudier B, et al. Free human cho rionic gonadotropin B subunit in gonadal and nongonadal neoplasms. Cancer Res 1992; 52: 3901–3907
   PubMed Web of Science ®Google Scholar
• Weisshaar G, Hiyama J, Renwick A. Site-spe cific N-glycosylation of human chorionic gona dotrophin structural analysis of glycopeptides by one- and two-dimensional 1H NMR spec troscopy. Glycobiology 1991; 1: 393–404
   PubMedGoogle Scholar
• Birken S, Gawinowicz M A, Kardana A, Cole L A. The heterogeneity of human chorionic go nadotropin (hCG). II. Characteristics and origins of nicks in hCG reference standards. Endocrinol 1991; 129: 1551–1558
   PubMed Web of Science ®Google Scholar
• Cole L A, Kardana A, Andrade G P, Gawinowicz M A, Morris J C, Bergert E R, et al. The heteroge neity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immuno logical activities of nicked hCG. Endocrinol 1991; 129: 1559–1567
   PubMed Web of Science ®Google Scholar
• Kardana A, Elliott M M, Gawinowicz M-A, Bir ken S, Cole L A. The heterogeneity of human chorionic gonadotropin (hCG). I. Characteriza tion of peptide heterogeneity in 13 individual preparations of hCG. Endocrinol 1991; 129: 1541–1550
   PubMed Web of Science ®Google Scholar
• Lustbader J, Birken S, Pollak S, Levinson L, Bernstine E, Hsiung N, Canfield R. Characteri zation of the expression products of recombi nant human choriogonadotropin and subunits. J Biol Chem 1987; 262: 14204–12
   PubMed Web of Science ®Google Scholar
• Louvet J-P, Ross G T, Birken S, Canfield R E. Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J Clin Endocrinol Metab 1974; 39: 1155–1158
   PubMed Web of Science ®Google Scholar
• Matsuura S, Ohashi M, Chen H C, Hodgen G D. A human chorionic gonadotropin-specific antiserum against synthetic peptide analogs to the carboxyl-terminal peptide of its beta-sub-unit. Endocrinol 1979; 104: 396–401
   PubMed Web of Science ®Google Scholar
• Stevens V C, Chou W S, Powell J E, Lee A C, Smoot J. The identification of peptide se quences of human chorionic gonadotropin con taining a conformational epitope. Immunol Lett 1986; 12: 11–18
   PubMed Web of Science ®Google Scholar
• Troalen F, Razafindratsita A, Puisieux A, Voelt-zel T, Bohuon C, Bellet D, Bidart J M. Structural probing of human lutropin using antibodies raised against synthetic peptides constructed by classical and multiple antigen peptide system approaches. Mol Immunol 1990; 27: 363–8
   PubMed Web of Science ®Google Scholar
• Troalen F, Bellet D H, Ghillani P, Puisieux A, Bohuon C J, Bidart J M. Antigenic determinants on human choriogonadotropin alpha-subunit. II. Immunochemical mapping by a monoclonal antipeptide antibody. J Biol Chem 1988; 263: 10370–10376
   PubMed Web of Science ®Google Scholar
• Talwar G P, Ramakrishnan S, Das C. Recent Advances in Reproduction and Regulation of Fertility, G P Talwar. North Hol land, Amsterdam 1979; 453–466
   Google Scholar
• Marshall J R, Hammond C B, Ross G T, Jacobson A, Rayford P, Odell W D. Plasma and urinary chorionic gonadotropin during early human pregnancy. Obstet Gynecol 1968; 32: 760–764
   PubMed Web of Science ®Google Scholar
• Morgan F J, Birken S, Canfield R E. The amino acid sequence of human chorionic gonado tropin: The a subunit and the fi subunit. J Biol Chem 1975; 250: 5247–5258
   PubMed Web of Science ®Google Scholar
• Birken S, Canfield R E. Chemistry and immuno-chemistry of human chorionic gonadotropin. Chorionic gonadotropin, S Segal. Plenum Press, New York 1980; 65–88
   Google Scholar
• Birken S, Agosto G, Amr S, Nisula B, Cole L, Lewis J, Canfield R. Characterization of anti-sera distinguishing carbohydrate structures in the pi-carboxyl-terminal region of human cho rionic gonadotropin. Endocrinol 1988; 122: 2054–2063
   PubMed Web of Science ®Google Scholar
• Ehrlich P H, Moustafa Z A, Krichevsky A, Bir ken S, Armstrong E G, Canfield R E. Characteri zation and relative orientation of epitopes for monoclonal antibodies and antisera to human chorionic gonadotropin. Am J Reprod Immu nol Microbiol 1985; 8: 48–54
   PubMed Web of Science ®Google Scholar
• Gupta S K, Talwar G P. Development of hybri-domas secreting anti-human chorionic gonado tropin antibodies. Indian J Exp Biol 1980; 18: 1361–5
   PubMed Web of Science ®Google Scholar
• Bellet D, Bidart J-M, Motte P, Lumbrosco J, Berche C, Schlumberger M, Bohoun C. In vitro and in vivo utilization of monoclonal anti bodies to beta subunit of human chorionic go nadotropin. Hybridoma 1982; 1: 218–9
   Google Scholar
• Stenman U-H, Tanner P, Ranta T, Schroder J, Seppala M. Monoclonal antibodies to chorionic gonadotropin: Use in a rapid radioimmunoas say for gynecologic emergencies. Obstet Gyne col 1982; 59: 375–377
   Google Scholar
• Stenman U-H, Alfthan H, Myllynen L, Seppala M. Ultrarapid and highly sensitive time-re solved fluoroimmunoassay for human cho rionic gonadotropin. Lancet 1983; 2: 647–649
   PubMed Web of Science ®Google Scholar
• Schwarz S, Berger P, Wick G. The antigenic surface of human chorionic gonadotropin as mapped by murine monoclonal antibodies. En docrinol 1986; 118: 189–197
   Google Scholar
• Berger P, Klieber R, Panmoung W, Maders-bacher S, Wolf H, Wick G. Monoclonal anti bodies against free subunits of human cho rionic gonadotropin. J Endocrinol 1990; 125: 301–309
   PubMed Web of Science ®Google Scholar
• Norman R J, Poulton T, Gard T, Chard T. Mono clonal antibodies to human chorionic gonadotropin: Implications for antigenic mapping, im-munoradiometric assays, and clinical applica tions. ] Clin Endocrinol Metab 1985; 61: 1031–1038
   PubMed Web of Science ®Google Scholar
• Bidart J-M, Bellet D H. Structure-Function Relationship of Gona dotropins, D H Bellet, J M Bidart. Raven Press, New York 1989; 21–33
   Google Scholar
• Moyle W R, Matzuk M M, Campbell R K, Cogliani E, Dean E D, Krichevsky A, et al. Localiz ation of residues that confer antibody binding specificity using human chorionic gonado tropin/Luteinizing hormone beta subunit chimeras and mutants. J Biol Chem 1990; 265: 8511–8518
   PubMed Web of Science ®Google Scholar
• Ryan R J, Keutmann H T, Charlesworth M C, McCormick D J, Milius R P, Calvo F O, Vutyava-nich H. Structure-function relationships in go nadotropins. Rec Prog Horm Res 1987; 43: 383–429
   PubMedGoogle Scholar
• Charlesworth M C, Bergert E R, Morris J C, McCormick D J, Ryan R J. The antigenic struc ture of the human glycoprotein hormone alpha-subunit: III. Solution- and solid-phase mapping using synthetic peptides. Endocrinol 1991; 128: 2907–2915
   PubMed Web of Science ®Google Scholar
• Fiddes J C, Talmadge K. Structure, expression, and evolution of the genes for the human gly coprotein hormones. Rec Prog Horm Res 1984; 40: 43–78
   PubMedGoogle Scholar
• Talmadge K, Boorstein W R, Vamvakopoulos N C, Gething M J, Fiddes J C. Only three of the seven human chorionic gonadotropin beta sub-unit genes can be expressed in the placenta. Nucleic Acids Res 1984; 12: 8415–8436
   PubMed Web of Science ®Google Scholar
• Otani T, Otani F, Krych M, Chaplin D D, Boime I. Identification of a promoter region in the CG beta gene cluster [published erratum appears in J Biol Chem 1988 Dec 15;263(35):19256–7]. J Biol Chem 1988; 263: 7322–7329
   PubMed Web of Science ®Google Scholar
• Bo M, Boime I. Identification of the transcrip tionally active genes of the chorionic gonado tropin beta gene cluster in vivo. J Biol Chem 1992; 267: 3179–3184
   PubMed Web of Science ®Google Scholar
• Shen Q X, Bahl O P. cDNA-derived amino acid sequences of choriocarcinoma alpha- and beta-subunits of human choriogonadotropin. Mol Cell Endocrinol 1990; 72: 167–173
   PubMed Web of Science ®Google Scholar
• Pettersson K, Ding Y-D, Huhtaniemi I. An im munological anomalous luteinizing hormone variant in a healthy woman. J Clin Endocrinol Metab 1992; 74: 164–171
   PubMed Web of Science ®Google Scholar
• Amr S, Wehmann R, Birken S, Canfield R, Nisula B. Characterization of a carboxyterminal peptide fragment of the human choriogonado tropin fl-subunit excreted in the urine of a woman with choriocarcinoma. J Clin Invest 1983; 71: 329–339
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Miyazaki S, Ishiguro M. A nicked p-subunit of human chorionic gonadotropin purified from pregnancy urine. J Biochem 1990; 107: 858–862
   PubMed Web of Science ®Google Scholar
• Bidart J-M, Puisieux A, Troalen F, Foglietti M J, Bouhon C, Bellet D. Characterization of a cleav age product in the human choriogonadotropin fi-subunit. Biochem Biophys Res Commun 1988; 154
   PubMed Web of Science ®Google Scholar
• Kardana A, Cole L A. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free S-subunit. Clin Chem 1992; 38: 26–33
   PubMed Web of Science ®Google Scholar
• Birken S, Canfield R E, Lauer R, Agosto G, Gabel M. Immunochemical determinants unique to human chorionic gonadotropin: importance of sialic acid for antisera generated to the human chorionic gonadotropin fi-subunit COOH-ter-minal peptide. Endocrinol 1980; 106: 1659–1664
   PubMed Web of Science ®Google Scholar
• Sairam M R, Linggen J, Bhargavi G N. Alter ations in antigenic structure of gonadotropins following deglycosylation. Biosci Rep 1988; 8: 271–278
   PubMed Web of Science ®Google Scholar
• Wide L, Hobson B. Some qualitative differences of hCG in serum from early and late pregnan cies and trophoblastic diseases. Acta Endocri nol (Copenh) 1987; 116: 465–72
   PubMed Web of Science ®Google Scholar
• Skarulis M C, Wehmann R E, Nisula B C, Blithe D L. Glycosylation changes in human chorionic gonadotropin and free alpha subunits as gesta tion progresses. J Clin Endocrinol Metab 1992; 75: 91–96
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H, Turpeinen U. Method dependence of interpretation of immu noassay results. Scand J Clin Lab Invest 1991; 51((Supplement 206))86–94
   Web of Science ®Google Scholar
• Tyrey L, Hammond C B. The hCG-P-subunit radioimmunoassay: potential error in hCG measurement related to choice of labeled antigen. Am J Obstet Gynecol 1976; 125: 160–165
   PubMed Web of Science ®Google Scholar
• Bellet D H, Ozturk M, Bidart J-M, Bohuon C J, Wands J R. Sensitive and specific assay of human chorionic gonadotropin (hCG) based on anti-peptide and anti-hCG monoclonal anti bodies: construction and clinical implications. J Clin Endocrinol Metab 1986; 63: 1319–1327
   PubMed Web of Science ®Google Scholar
• StockellHartree A, Shownkeen R C. Studies of human pituitary LH containing internally cleaved fi subunit. J Mol Endocrinol 1991; 6: 101–109
   PubMed Web of Science ®Google Scholar
• Papapetrou P D, Sakarelou N P, Braouzi H, Fessas P H. Ectopic production of human cho rionic gonadotropin (hCG) by neoplasms: The value of measurements of immunoreactive hCG in the urine as a screening procedure. Cancer 1980; 45: 2583–2592
   PubMed Web of Science ®Google Scholar
• Wang Y, Schwartz P E, Chambers J T, Cole L A. Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies. Gynecol Oncol 1988; 31: 91–100
   PubMed Web of Science ®Google Scholar
• O'Connor J F, Schlatterer J P, Birken S, Krichev-sky A, Armstrong E G, McMahon D, Canfield R E. Development of highly sensitive immu noassays to measure human chorionic gonado tropin, its fi-subunit, and fJ core fragment in the urine: Application to malignancies. Cancer Res 1988; 48: 1361–1366
   PubMed Web of Science ®Google Scholar
• Cole L A, Schwartz P E, Wang Y. Urinary gona dotropin fragments (UGF) in cancers of the fe male reproductive system. I. Sensitivity and specificity, comparison with other markers. Gynecol Oncol 1988; 31: 82–90
   PubMed Web of Science ®Google Scholar
• Kardana A, Taylor M E, Southall P J, Boxer G M, Rowan A J, Bagshawe K D. Urinary gonadotro-phin peptide isolation and purification, and its immunohistological distribution in normal and neoplastic tissues. Br J Cancer 1988; 58: 281–286
   PubMed Web of Science ®Google Scholar
• Birken S, Armstrong E G, Kolks M AG, Cole L A, Agosto G M, Krichevsky A, et al. Structure of the human chorionic gonadotropin fi-subunit fragment from pregnancy urine. Endocrinol 1988; 123: 572–583
   PubMed Web of Science ®Google Scholar
• Krichevsky A, Armstrong E G, Schlatterer J, Bir ken S, O'Connor J, Bikel K, et al. Preparation and characterization of antibodies to the uri nary fragment of the human chorionic gonado tropin fi-subunit. Endocrinol 1988; 123: 584–593
   PubMed Web of Science ®Google Scholar
• Krichevsky A, Birken S, O'Connor J, Bikel K, Schlatterer J, Yi C, et al. Development and char acterization of a new, highly specific antibody to the human chorionic gonadotropin-B frag ment. Endocrinol 1991; 128: 1255–1264
   PubMed Web of Science ®Google Scholar
• Weber T H, Kapyaho K I, Tanner P. Endogenous interference in immunoassays in clinical chem istry. A review. Scand J Clin Lab Invest 1990; 50(Suppl 201)77–82
   PubMed Web of Science ®Google Scholar
• Bonner O P. Interference of complement with the binding of carcinoembryonic antigen to solid-phase monoclonal antibodies. J Immunol Meth 1989; 121: 85–93
   PubMed Web of Science ®Google Scholar
• Boerman O C, Segers M F, Poels L G, Kenemans P, Thomas C M. Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay [see comments]. Clin Chem 1990; 36: 888–891
   PubMed Web of Science ®Google Scholar
• Turpeinen U, Lehtovirta P, Alfthan H, Stenman U-H. Evaluation of chromatographic methods for removal of immunoglobulin interference in an immunoradiometric assay for CA 125 antigen. Clin Chem 1990; 36: 1333–1338
   PubMed Web of Science ®Google Scholar
• Braunstein G D, Bloch S K, Rasor J L, Winikoff J. Characterization of antihuman chorionic gonadotropin serum antibody appearing after ovu lation induction. J Clin Endocrinol Metab 1983; 57: 1164–72
   PubMed Web of Science ®Google Scholar
• Odell W D, Griffin J. Pulsatile secretion of human chorionic gonadotropin in normal adults. N Engl J Med 1987; 317: 1688–1691
   PubMed Web of Science ®Google Scholar
• Braunstein G D. Pulsatile secretion of human chorionic gonadotropin [letter]. N Engl J Med 1988; 319: 53–4
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Alfthan H, Koskimies A, Seppala M, Pettersson K, Lövgren T. Monitoring the LH surge by ultrarapid and highly sensitive immunofluorometric assay. Ann NY Acad Sci 1985; 442: 544–550
   PubMed Web of Science ®Google Scholar
• Rao C V, Hussa R O, Carmen F R, Rinke M L, Cook C L, Yussman M A. Stability of human chorionic gonadotropin and its alpha subunit in blood. Am J Obstet Gynecol 1983; 146: 65–68
   PubMed Web of Science ®Google Scholar
• deMedeiros S F, Amato F, Norman R J. Stability of immunoreactive |J-core fragment of hCG. Obstet Gynecol 1991; 77: 53–59
   PubMed Web of Science ®Google Scholar
• Wehmann R E, Blithe D L, Akar A H, Nisula B C. Disparity between fi-core levels in pregnancy urine and serum: Implications for the origin of urinary fi-core. J Clin Endocrinol Metab 1990; 70: 371–378
   PubMed Web of Science ®Google Scholar
• Dufau M L, Pock R, Neubauer A, Catt K J. In vitro bioassay of LH in human serum: the rat interstitial cell testosterone (RICT) assay. J Clin Endocrinol Metab 1976; 42: 958–69
   PubMed Web of Science ®Google Scholar
• VanDamme M P, Robertson D M, Diczfalusy E. An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta En docrinol (Copenh) 1974; 77: 655–671
   PubMed Web of Science ®Google Scholar
• Kraiem Z, Sadeh O, Yosef M. Iodide uptake and organification, tri-iodothyronine secretion, cy clic AMP accumulation and cell proliferation in an optimized system of human thyroid follicles cultured in collagen suspended in serum-free medium. J Endocr 1991; 131: 499–506
   PubMed Web of Science ®Google Scholar
• Jia X C, Oikawa M, Bo M, Tanaka T, Ny T, Boime I, Hsueh A J. Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species. Mol Endocri nol 1991; 5: 759–68
   PubMedGoogle Scholar
• Nagayama Y, Kaufman K D, Seto P, Rapoport B. Molecular cloning, sequence and functional expression of the cDNA for the human thyro tropin receptor. Biochem Biophys Res Com-mun 1989; 165: 1184–1190
   PubMed Web of Science ®Google Scholar
• Canfield R E, Ross G T. A new reference prep aration of human chorionic gonadotropin and its subunits. Bull WHO 1976; 54: 436–470
   Web of Science ®Google Scholar
• WHO. expert committee on biological stand ardization. Twenty-sixth report. Bull Wld Hlth Org Tech Rep Ser 1975, No. 565
   Google Scholar
• Bangham D R, Grab B. The Second International Standard for chorionic gonadotrophin. Bull Wld Hlth Org 1964; 31: 111–125
   PubMed Web of Science ®Google Scholar
• Stoning P L, Gaines-Das R E, Bangham D R. In ternational reference preparation of human chorionic gonadotrophin for immunoassay: Potency estimates in various bioassay and pro tein binding assay systems; and international reference preparations of a and fi subunits of human chorionic gonadotrophin for immu noassay. J Endocrinol 1980; 84: 295–310
   PubMed Web of Science ®Google Scholar
• WHO. expert committee on biological stand ardization. Thirty-seventh report. Bull Wld Hlth Org Tech Rep Ser 1987, No. 760
   Google Scholar
• Moss J, Ross P, Agosto G, Birken S, Canfield R, Vaughan M. Mechanism of action of choleragen and glycopeptide hormones. Is the nicotina mide adenine dinucleotide glycohydrolase ac tivity observed in purified hormon prepara tions intrinsic to the hormone? Endocrinology 1978; 102: 415–419
   Google Scholar
• Wehmann R E, Blithe D L, Akar A H, Nisula B C. 6-core fragments are contaminants of the World Health Organization reference prepara tions of human choriogonadotropin and its a-subunit. J Endocrinol 1988; 117: 147–152
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Nishimura R, Kobata A., Belief D, Bidart J M. Structure-function of gonado tropins. Raven Press, New York 1989; 45–58
   Google Scholar
• Pollak S, Halpine S, Chait B T, Birken S. High resolution high performance liquid chromato graphy fingerprinting of purified human cho rionic gonadotropin demonstrates that oxida tion is a cause of hormone heterogeneity. Endo crinol 1990; 126: 199–208
   Google Scholar
• Chard T. An introduction to radioimmunoas say and related techniques. Else vier, New York 1987
   Google Scholar
• Ekins R P. The precision profile: Its use in assay design, assessment and quality control. Immunoassays for clinical chemistry, W M Hunter, JET Corrie. Churchill Living stone, New York 1983; 76–105
   Google Scholar
• Ragget P. Data processing. Principles and practice of immu noassay, C P Price, D J New man. Stockton press, New York 1991; 190–218
   Google Scholar
• Sturgeon C, Seth J, Al-Sadie R. Comm Lab Med 1992; 1: 39–40
   Google Scholar
• Wilcox A J, Weinberg C R, O'Connor J F, Baird D D, Schlatterer J P, Canfield R E, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189–94
   PubMed Web of Science ®Google Scholar
• Stenman U-H. Sensitive pregnancy tests. Duodecim 1988; 104: 677–9
   Google Scholar
• Wald N J, Cuckle H S, Densem J W, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early preg nancy [published erratum appears in BMJ 1988 Oct 22;297(6655):1029]. Brit Med J 1988; 297: 883–7
   PubMed Web of Science ®Google Scholar
• Spencer K. Evaluation of an assay of the free beta-subunit of choriogonadotropin and its potential value in screening for Down's syn drome [see comments]. Clin Chem 1991; 37: 809–14
   PubMed Web of Science ®Google Scholar
• Thomas C M, Segers M F, Leloux A M, Houx P C. Comparison of the analytical characteristics of ten urinary hCG tests for early pregnancy diag nosis. Ann Clin Biochem 1986
   PubMed Web of Science ®Google Scholar
• Bartlett N L, Freiha F S, Torti F M. Serum markers in germ cell neoplasms. Hematol Oncol Clin North Am 1991; 5: 1245–1260
   PubMed Web of Science ®Google Scholar
• Bates S E. Clinical applications of serum tumor markers. Ann fnt Med 1991; 115: 623–638
   PubMed Web of Science ®Google Scholar
• Huff B C. Gestational trophoblastic disease. NAACOGS Clin Issu Perinat Womens Health Nurs 1990; 1: 453–458
   PubMedGoogle Scholar
• Berkowitz R S, Goldstein D P. Diagnosis and management of the primary hydatidiform mole. Obstet Gynecol Clin North Am 1988; 15
   PubMed Web of Science ®Google Scholar
• Miller D S, Lurain J R. Classification and staging of gestational trophoblastic tumors. Obstet Gynecol Clin North Am 1988; 15: 477–490
   PubMed Web of Science ®Google Scholar
• Khazaeli M B, Hedayat M M, Hatch K D, To A CW, Soong S-J, Shingleton H M, et al. Radioimmunoassay of free 6-subunit of human chorionic gonadotropin as a prognostic test for persisitent trophoblastic disease in molar preg nancy. Am J Obstet Gynecol 1986; 155: 320–324
   PubMed Web of Science ®Google Scholar
• Ozturk M, Berkowitz R, Goldstein D, Belief D, Wands J R. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease. Am J Obstet Gynecol 1988; 158: 193–8
   PubMed Web of Science ®Google Scholar
• Hussa R O. Human chorionic gonadotropin, a clinical marker: review of its biosynthesis. Li-gand Review 1981; 3: 6–44
   Google Scholar
• Murphy P, Johnson D H. Staging and prognos tic factors in nonseminomatous testicular cancer. Hematol Oncol Clin North Am 1991; 5: 1233–1243
   PubMed Web of Science ®Google Scholar
• Aass N, Klepp O, Cavallin-Stahl E, Dahl O, Wicklund H, Unsgaard B, et al. Prognostic fac tors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol 1991; 9: 818–826
   PubMed Web of Science ®Google Scholar
• Jensen J L, Venner P M. Predictive factors for outcome in treatment of metastatic nonsemino matous germ cell tumors. Urology 1992; 39: 237–242
   PubMed Web of Science ®Google Scholar
• Horwich A, Peckham M J. Transient rumor mar ker elevation following chemotherapy for germ cell tumors of the testis. Cancer Treat Rep 1986; 70: 1329–1331
   PubMedGoogle Scholar
• Lange P H, Nochomovitz L E, Rosai J, Fraley E E, Kennedy B J, Bosl G, et al. Serum alpha-fetopro-tein and human chorionic gonadotropin in pa tients with seminoma. J Urol 1980; 124: 472–8
   PubMed Web of Science ®Google Scholar
• Sailer B, Clara R, Spottl G, Siddle K, Mann K. Testicular cancer secretes intact human chorio gonadotropin (hCG) and its free beta-subunit: evidence that hCG (+hCG-beta) assays are the most reliable in diagnosis and follow-up [see comments]. Clin Chem 1990; 36: 234–9
   PubMed Web of Science ®Google Scholar
• Mumperow E, Hartmann M. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications. J Urol 1992; 147: 1041–3
   PubMed Web of Science ®Google Scholar
• Iles R K, Purkis P E, Whitehead P C, Oliver R T, Leigh I, Chard T. Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine ‘normal’ and malignant epithe lial cells. Br J Cancer 1990; 61: 663–6
   PubMed Web of Science ®Google Scholar
• Oberg K, Wide L. hCG and hCG subunits as tumour markers in patients with endcocrine pancreatic tumours and carcinoids. Acta Endo crinol 1981; 98: 256–260
   PubMed Web of Science ®Google Scholar
• Cole L A, Birken S. Origin and occurrence of human chorionic gonadotropin p-subunit core fragment. Mol Endocrinol 1988; 2: 826–830
   Google Scholar
• Ruddon R W, Anderson C, Meade K S, Alden-derfer P H, Neuwald P D. Content of gonado tropins in cultured human malignant cells and effects of sodium butyrate treatment on gona dotropin secretion by HeLa cells. Cancer Res 1979; 39: 3885–92
   PubMed Web of Science ®Google Scholar
• Iles R K, Oliver R TD, Kitau M, Walker C, Chard T. In vitro secretion of human chorionic gona dotrophin by bladder tumour cells. Br J Cancer 1987; 55: 623–626
   PubMed Web of Science ®Google Scholar
• Hoermann R, Spoettl G, Moncayo R, Mann K. Evidence for the presence of human chorionic gonadotropin (hCG) and free beta-subunit of hCG in the human pituitary. J Clin Endocrinol Metab 1990; 71: 179–86
   PubMed Web of Science ®Google Scholar